Proportionate approach to the REACH universal per- and polyfluoroalkyl substances restriction proposal
Position Paper
27 Apr 2025
Digital, Environment, Healthcare, Energy

ECHA and its committees continue to review a proposal for a universal PFAS restriction. This position paper responds to the ECHA progress update reported on 20 November 2024 and recommends restriction options other than a ban, that account for different PFAS properties and risk profiles. In light of the upcoming Chemicals Industry Package and the revision of the Regulation on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), the Commission must establish a more proportionate, predictable and enforceable restriction.

Related items

Position Paper
26 Jun 2026

CBAM extension: get implementation right before expanding scope

The Carbon Border Adjustment Mechanism (CBAM) will test whether the EU can address carbon leakage while keeping investment in Europe. As implementation of the CBAM advances, companies face costs and reporting duties under rules that are still taking shape. Preventing carbon leakage matters. However, the CBAM should work in practice before scope extension is considered. Moving too soon could place burdens on companies and disrupt value chains, with consequences for investment and trade. The focus should be on avoiding measures that introduce further uncertainty and extending proposed safeguards in the Temporary Decarbonisation Fund beyond 2027. Learn how to shape the CBAM so it prevents carbon leakage while maintaining competitiveness. 

Energy
Read more
Read more about CBAM extension: get implementation right before expanding scope
News
24 Jun 2026

A medical milestone, made in Denmark

Pfizer selected Denmark as the site of the largest vaccine registry study ever undertaken, demonstrating how Europe can attract world-leading life sciences investment when the right conditions are in place. Beginning in 2024, Pfizer partnered with researchers at the Center for Translational Cardiology and Pragmatic Randomized Trials at Herlev-Gentofte Hospital in Copenhagen to assess whether its respiratory syncytial virus vaccine could reduce hospitalisations in adults. Denmark’s innovation-friendly environment, national digital mailbox eBoks and world-class health registries enabled researchers to invite almost the entire adult population to take part, helping recruit more than 500,000 participants. Study materials were made available online, allowing participants to provide informed consent from home, while health registries supported comprehensive tracking and analysis. This milestone shows how strong public-private collaboration and a supportive policy framework can help Europe deliver clinical research at scale and improve health outcomes for citizens. Read the full story on Invested in Europe

Healthcare
Read more
Read more about A medical milestone, made in Denmark
News
19 Jun 2026

Bringing energy and climate priorities to Strasbourg

Europe’s clean industrial transition will depend on policies that can unlock investment, strengthen energy systems and support sustainable transport. From Tuesday, 16 to Wednesday, 17 June, AmCham EU travelled to the European Parliament in Strasbourg, France for a series of meetings on EU transport, energy and climate policy developments. The delegation engaged with Members of the European Parliament and political group advisers to share business perspectives on Europe’s clean industrial transition. Discussions focused on the Industrial Accelerator Act, the revision of the EU Emissions Trading System, the Carbon Border Adjustment Mechanism, the Grids Package and energy security. Members highlighted the need for predictable, technology-neutral rules that support investment, strengthen Europe’s industrial base and preserve openness to trusted partners.

Industry
Climate
Energy
Read more
Read more about Bringing energy and climate priorities to Strasbourg